A professor of bioethics at New York University raised the issue of antirejection drugs, which are needed after a transplant but can prove toxic over time. "We don't worry about it when it comes to the heart, because without the transplant they're dead," said Arthur Caplan. "But if you transplant someone at 20 with a new penis, and their kidneys fail at 30, is that a success?"